Changes for Table matviews.mv_protocol

02/04/2011 05:45 AM

Open History Table in phpPgAdmin

Type of Change indholder ind_number protocol_size parent_protocol protocol_population current_version network_name protocol_duration_in_months operations_directory protocol_name version exclude_report daidswsmaintain_exclude daidsstudy_id stage_name indanniversary_date record_add_user protocol_title protocol_rationale partner_protocol ind_contact record_mod_dt root_protocol_id protocol_description ind_report_due_date status_name protocol_id record_mod_user trial_design_name record_add_dt
INSERTED DAIDS 55.690 None None None 1 MTN 24.0 None MTN 018 - Tenofovir Expanded Access 1 0 0 11818 Protocol Development None FHCRC\missy Committed to Having Options for Interventions to Control the Epidemic: a Follow-up Study to MTN-003 None None None 2011-02-03 09:20:33.943000 1056 Phase IIIB Tenofovir gel expanded access None In Development 1056 FHCRC\missy Phase IIIB 2011-02-03 09:16:50.350000
UPDATED - Before International Partnership for Microbicides (IPM) 69,022 48 None None 1 MTN 4.0 None MTN 012 1 0 0 11771 Study Setup (Pending) None FHCRC\missy Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures None None None 2010-11-30 11:30:50.470000 1022 Dapivirine Male Tolerance None In Development 1022 FHCRC\missy Phase I 2010-01-15 14:02:40.477000
UPDATED - After International Partnership for Microbicides (IPM) 69,022 48 None None 1 MTN 4.0 None MTN 012 1 0 0 11771 Study Setup (Pending) None FHCRC\missy Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures None None None 2011-02-03 07:27:47.250000 1022 Dapivirine Male Tolerance None In Development 1022 FHCRC\missy Phase I 2010-01-15 14:02:40.477000
UPDATED - Before DAIDS None 32 None None 1 MTN 6.0 None MTN 013 1 0 0 11772 Protocol Development None FHCRC\missy Phase 1 Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring None None None 2011-01-07 12:43:15.373000 1023 IPM Dap/Mav Ring Study None In Development 1023 FHCRC\missy Phase I 2010-01-15 14:05:16.867000
UPDATED - After DAIDS None 32 None None 1 MTN 6.0 None MTN 013 1 0 0 11772 Protocol Development None FHCRC\missy Phase 1 Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring None None None 2011-02-03 07:31:43.093000 1023 IPM Dap/Mav Ring Study None In Development 1023 FHCRC\missy Phase I 2010-01-15 14:05:16.867000
UPDATED - Before CONRAD None 90 None healthy HIV-uninfected females 15-18 years old 1 MTN 12.0 None Tenofovir in adolescents 1 0 0 None Concept (Proposed) None FHCRC\missy Safety and Tolerability of 1% Tenofovir Gel in Adolescent Females None None None 2011-01-07 11:12:34.873000 1048 Tenofovir in adolescents None In development 1048 FHCRC\missy Phase II 2010-12-16 16:24:56.560000
UPDATED - After CONRAD None 90 None healthy HIV-uninfected females 15-18 years old 1 MTN 12.0 None MTN-021 - Tenofovir in adolescents 1 0 0 None Concept (Proposed) None FHCRC\missy Safety and Tolerability of 1% Tenofovir Gel in Adolescent Females None None None 2011-02-03 08:49:56.497000 1048 MTN-021 None In development 1048 FHCRC\missy Phase II 2010-12-16 16:24:56.560000
UPDATED - Before DAIDS None None None 180 HIV-uninfected pregnant women 18-45 years old 1 MTN 12.0 None Tenofovir in Pregnancy 1 0 0 None Concept (Proposed) None FHCRC\missy Extended Safety of Tenofovir Gel in Pregnancy None None None 2011-01-07 11:21:21.913000 1050 Tenofovir in Pregnancy None In development 1050 FHCRC\missy Phase II 2011-01-07 11:15:11.637000
UPDATED - After DAIDS None None None 180 HIV-uninfected pregnant women 18-45 years old 1 MTN 12.0 None MTN-019 - Tenofovir in Pregnancy 1 0 0 None Concept (Proposed) None FHCRC\missy Extended Safety of Tenofovir Gel in Pregnancy None None None 2011-02-03 08:50:24.713000 1050 MTN-019 None In development 1050 FHCRC\missy Phase II 2011-01-07 11:15:11.637000
UPDATED - Before None None None None 32 HIV-uninfected, sexually-active, heterosexual couples 1 MTN 9.0 None MTN-011 1 0 0 None Protocol Development None FHCRC\missy Evaluation of the Pharmacokinetics and Pharmacodynamics of Tenofovir Gel Following Coitus None None None 2011-02-02 17:57:45.503000 1053 MTN-011 None In Development 1053 FHCRC\missy Phase I 2011-02-02 17:55:23.520000
UPDATED - After None None None None 32 HIV-uninfected, sexually-active, heterosexual couples 1 MTN 9.0 None MTN-011 - PK/PD of TNF Following Coitus 1 0 0 None Protocol Development None FHCRC\missy Evaluation of the Pharmacokinetics and Pharmacodynamics of Tenofovir Gel Following Coitus None None None 2011-02-03 09:22:49.363000 1053 MTN-011 None In Development 1053 FHCRC\missy Phase I 2011-02-02 17:55:23.520000
UPDATED - Before None None None None HIV-uninfected African women 1 MTN 24.0 None MTN-020 1 0 0 None Protocol Development None FHCRC\missy IPM Phase III Intravaginal Ring Study - Dapivirine None None None 2011-02-02 18:02:52.957000 1054 MTN-020 None In Development 1054 FHCRC\missy Phase III 2011-02-02 18:02:03.800000
UPDATED - After None None None None HIV-uninfected African women 1 MTN 24.0 None MTN-020 - IPM Phase III Ring 1 0 0 None Protocol Development None FHCRC\missy IPM Phase III Intravaginal Ring Study - Dapivirine None None None 2011-02-03 08:50:47.463000 1054 MTN-020 None In Development 1054 FHCRC\missy Phase III 2011-02-02 18:02:03.800000
UPDATED - Before None None None None 32 HIV-uninfected women 1 MTN 6.0 None MTN-014 1 0 0 None Concept (Proposed) None FHCRC\missy A PHASE 1 CROSSOVER TRIAL EVALUATING THE SAFETY AND PHARMACOKINETICS OF 1% TENOFOVIR GEL IN THE RECTAL AND VAGINAL COMPARTMENTS FOLLOWING LOCAL ADMINISTRATION IN EACH ONE OF THESE COMPARTMENTS None None None 2011-02-02 18:14:10.800000 1055 MTN-014 None In development 1055 FHCRC\missy Phase I 2011-02-02 18:14:10.800000
UPDATED - After None None None None 32 HIV-uninfected women 1 MTN 6.0 None MTN-014 - Safety and PK of TNF Vag/Rectal 1 0 0 None Concept (Proposed) None FHCRC\missy A PHASE 1 CROSSOVER TRIAL EVALUATING THE SAFETY AND PHARMACOKINETICS OF 1% TENOFOVIR GEL IN THE RECTAL AND VAGINAL COMPARTMENTS FOLLOWING LOCAL ADMINISTRATION IN EACH ONE OF THESE COMPARTMENTS None None None 2011-02-03 09:23:53.490000 1055 MTN-014 None In development 1055 FHCRC\missy Phase I 2011-02-02 18:14:10.800000
DELETED None None None None None 1 MTN 24.0 None MTN 018 1 0 0 None Protocol Development None FHCRC\missy None None None None 2011-02-02 18:15:07.720000 1024 Phase IIIB Tenofovir gel expanded access None In Development 1024 FHCRC\missy Phase IIIB 2010-01-15 14:08:34.617000